Z

Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702

Watchlist Manager
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
Watchlist
Price: 16.9 CNY -2.99% Market Closed
Market Cap: 5.9B CNY
Have any thoughts about
Zhejiang Tianyu Pharmaceutical Co Ltd?
Write Note

Gross Margin
Zhejiang Tianyu Pharmaceutical Co Ltd

34.6%
Current
32%
Average
48.4%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
34.6%
=
Gross Profit
897.3m
/
Revenue
2.6B

Gross Margin Across Competitors

Country CN
Market Cap 5.8B CNY
Gross Margin
35%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 756.3B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 2.7T DKK
Gross Margin
85%
Country US
Market Cap 349.7B USD
Gross Margin
69%
Country US
Market Cap 251.6B USD
Gross Margin
77%
Country CH
Market Cap 200.1B CHF
Gross Margin
73%
Country UK
Market Cap 162.1B GBP
Gross Margin
82%
Country CH
Market Cap 171.5B CHF
Gross Margin
75%
Country US
Market Cap 151.4B USD
Gross Margin
71%
No Stocks Found

Zhejiang Tianyu Pharmaceutical Co Ltd
Glance View

Market Cap
5.8B CNY
Industry
Pharmaceuticals

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and intermediates. The company is headquartered in Taizhou, Zhejiang and currently employs 4,991 full-time employees. The company went IPO on 2017-09-19. The firm operates three segments. The Pharmaceutical Intermediates segment include hypertension drugs raw materials, anti-asthma drugs raw materials and anticoagulant drugs raw materials. The Active Pharmaceutical Ingredients (API) segment is engaged in production of high blood pressure drug intermediates, anti-asthma drug intermediates and antiviral drug intermediates. The firm also operates Other segment. The firm sells its products to both domestic and international markets, including Europe, the United States, Japan, South Korea and so on.

Intrinsic Value
20.88 CNY
Undervaluation 19%
Intrinsic Value
Price
Z

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
34.6%
=
Gross Profit
897.3m
/
Revenue
2.6B
What is the Gross Margin of Zhejiang Tianyu Pharmaceutical Co Ltd?

Based on Zhejiang Tianyu Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 34.6%.